The Role of Vitamin B2 in Cancer Cell Survival

Vitamin B2, or riboflavin, is essential for various bodily functions. It’s well-known for promoting healthy skin and helping in fat metabolism. Recent studies indicate it also supports the survival of cancer cells.

Specifically, it seems that cancer cells utilize vitamin B2 as a protective barrier against ferroptosis, a distinct type of cell death. When a cell’s membrane is damaged, it typically triggers a process leading to its disposal. However, researchers from the University of Würzburg in Germany have found that depriving cancer cells of vitamin B2 makes them more susceptible to ferroptosis.

According to biologist Vera Skafar from the University of Würzburg, “Vitamin B2 plays a crucial role in protecting cancer cells from ferroptosis, a special form of programmed cell death.”

The study revealed that vitamin B2 helps a protein known as FSP1, which acts to inhibit ferroptosis. Other research has highlighted the importance of FSP1, alongside GPX4 (glutathione peroxidase 4), in providing protection from ferroptosis. The researchers identified that FSP1 relies on a gene called RFK, responsible for processing vitamin B2 into usable forms.

Laboratory tests confirmed that vitamin B2 effectively fuels FSP1 via the RFK gene. Additionally, a compound known as roseoflavin, which resembles vitamin B2, was found to potentially disrupt this protective mechanism in cancer cells. In lab-grown cancer cells, roseoflavin appeared to encourage ferroptosis.

While this area of study is still in its infancy, it offers a potential avenue for targeting cancer cells without impacting vitamin B2 levels in healthy cells. The researchers see this as a previously overlooked approach to enhancing ferroptosis in cancer cells and similar scenarios.

It’s worth noting that our bodies don’t naturally produce vitamin B2, but it’s readily available in various foods such as dairy products, eggs, meats, and green vegetables. The aim of this study isn’t to suggest that vitamin B2 is harmful—it’s vital for survival. However, its protective role for cancer cells could complicate treatment efforts.

Finding a balance is key since ferroptosis also plays a beneficial role in eliminating biological waste when needed. Future research should focus on strategies to specifically target this aspect in cancer cells. Something like roseoflavin, specifically tailored to limit cancer cells’ access to vitamin B2, might pave the way for improved treatments.

There is also considerable potential for exploring the broader implications of this research. Ferroptosis, induced by oxidation, relates to many health conditions beyond cancer. Recent years have seen increased interest in ferroptosis, linking it to issues such as strokes and neurodegenerative diseases.

Biologist José Pedro Friedmann Angeli from the University of Würzburg emphasizes, “Increasing evidence suggests it also contributes to pathological processes in neurodegenerative diseases and tissue damage after organ transplants or ischemia-reperfusion injury.”

The findings of this research have been published in Nature Cell Biology.